Our Founder

Dr. Larry G Horgen

Dr. Larry G. Horgen is a distinguished medical researcher, physician, and entrepreneur, renowned for his pioneering contributions to the treatment of Amyotrophic Lateral Sclerosis (ALS). With an unwavering commitment to advancing medical science, he has collaborated with globally recognized institutions, including the World Health Organization (WHO), Harvard Institute of Public Health (HIPH), Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH).

Dr. Horgen earned his medical degree and PhD in Infectious Diseases from the prestigious University of Tromsø, Norway, where his academic brilliance and deep-rooted passion for improving global health set the foundation for his illustrious career. His expertise spans clinical practice, public health policy, and biomedical research, positioning him as a force to be reckoned with in the fight against ALS.

As the founder of Horgen Med, a leading biotech firm specializing in innovative treatments for neurodegenerative diseases, Dr. Horgen has spearheaded cutting-edge research initiatives that have brought new hope to patients worldwide. Recognizing the need for sustainable funding in medical research, he established the Horgen Med Foundation, a philanthropic arm that receives 50% of Horgen Med’s profits to support research, patient care, and advocacy programs focused on ALS and other critical health challenges.

Dr. Horgen’s lifelong dedication to medical breakthroughs and humanitarian efforts continues to shape the future of healthcare, making him a respected leader in the global medical community.